Quick Answer
CYTOKINETICS INC reported Net Income Loss of -$784.96 million for the year ending 2025.
- CYTOKINETICS INC showed a decrease of -33.2% in Net Income Loss from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: $8.44 million | Q1 2015: -$8.87 million | Q2 2015: -$10.55 million | Q3 2015: -$8.85 million | Q4 2015: -$9.23 million | Q1 2016: -$12.46 million | Q2 2016: -$11.61 million | Q3 2016: $33.36 million | Q4 2016: $7.16 million | Q1 2017: -$25.87 million | Q2 2017: -$29.08 million | Q3 2017: -$32.36 million | Q4 2017: -$40.48 million | Q1 2018: -$30.28 million | Q2 2018: -$27.52 million | Q3 2018: -$22.02 million | Q1 2019: -$29.37 million | Q2 2019: -$32.11 million | Q3 2019: -$29.57 million | Q1 2020: -$39.41 million | Q2 2020: -$40.78 million | Q3 2020: -$3.18 million | Q1 2021: -$47.10 million | Q2 2021: -$61.55 million | Q3 2021: -$76.09 million | Q1 2022: -$89.45 million | Q2 2022: -$19.82 million | Q3 2022: -$142.31 million | Q1 2023: -$131.29 million | Q2 2023: -$128.64 million | Q3 2023: -$129.42 million | Q1 2024: -$135.64 million | Q2 2024: -$143.32 million | Q3 2024: -$160.55 million | Q1 2025: -$161.38 million | Q2 2025: -$134.37 million | Q3 2025: -$306.18 million.
- Over the full 20 years of available data (2006 to 2025), CYTOKINETICS INC's Net Income Loss has declined by 1,274.3%.
- Historical annual values: Fiscal year 2025: -$784.96 million | Fiscal year 2024: -$589.53 million | Fiscal year 2023: -$526.24 million | Fiscal year 2022: -$388.96 million | Fiscal year 2021: -$215.31 million | Fiscal year 2020: -$127.29 million | Fiscal year 2019: -$121.69 million | Fiscal year 2018: -$106.29 million | Fiscal year 2017: -$127.79 million | Fiscal year 2016: $16.45 million | Fiscal year 2015: -$37.50 million | Fiscal year 2014: -$14.65 million | Fiscal year 2013: -$33.72 million | Fiscal year 2012: -$40.37 million | Fiscal year 2011: -$47.86 million | Fiscal year 2010: -$49.29 million | Fiscal year 2009: $24.54 million | Fiscal year 2008: -$56.37 million | Fiscal year 2007: -$48.89 million | Fiscal year 2006: -$57.12 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: